1297968

Sciegen Pharmaceuticals Inc — FEI 3008298016

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 19, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hauppauge, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)